Get started
Author

Fabian A. Mendoza-Ballesteros

Observed names: F. Mendoza Ballesteros, Fabian Mendoza-Ballesteros
Observed institution: Thomas Jefferson University
ORCID: 0000-0003-3901-5771
Observed ORCID: 0000-0003-3901-5771
OpenAlex ID: A5081007719
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
2020 · Dinesh Khanna, Celia J F Lin, et al. · The Lancet Respiratory Medicine · 662
PDF
Photoacoustic Oxygenation Quantification in Patients with Raynaud's: First-in-Human Results
2018 · John R. Eisenbrey, Maria Stanczak, et al. · Ultrasound in Medicine & Biology · 30
Analytical and clinical performance of the updated Elecsys Anti-TPO II assay for the detection of antibodies against thyroid peroxidase to aid in the diagnosis of autoimmune thyroid diseases
2026 · Kenneth D. Burman, Lowell R. Schmeltz, et al. · Clinical Chemistry and Laboratory Medicine (CCLM)
Pos0127 Quantitative Assessment of Finger Vascularity in Systemic Sclerosis Patients With Raynaud's Phenomenon Using Ultrasound Vascular Imaging
2022 · K. Nam, F. Mendoza Ballesteros, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 4
Citation count: 692
H-index: 2
I10-index: 2
Year
Topic
Type